Tag: Humira
Organon, Samsung Bioepis launch HUMIRA biosimilar HADLIMA in US
Organon & Co. and Samsung Bioepis revealed that HADLIMA (adalimumab-bwwd), a biosimilar referencing Humira (adalimumab), is now accessible to patients in the United States. This ... Read More
Pfizer, AbbVie resolve IP matters for adalimumab biosimilar
Pfizer adalimumab biosimilar update : Pfizer and AbbVie have signed licensing agreements to resolve all global intellectual property (IP) matters pertaining to the former’s proposed ... Read More
Mylan launches Humira biosimilar Hulio across Europe
Mylan has launched Hulio, a biosimilar to AbbVie's Humira (adalimumab), in major markets in Europe, a month after its approval from the European Commission for ... Read More
Humira biosimilar Cyltezo meets objective in phase 3 plaque psoriasis trial
German pharma company Boehringer Ingelheim said that Cyltezo, a biosimilar to AbbVie psoriasis drug Humira, achieved clinical equivalence to the reference product in a phase ... Read More
Hyrimoz EC approval : Novartis biosimilar of AbbVie Humira approved in EU
Hyrimoz EC approval : Novartis’ Sandoz has bagged approval for Hyrimoz (adalimumab), a biosimilar of AbbVie’s Humira (adalimumab), in Europe for all indications of the ... Read More